Gaucher disease type I: Assessment of basal metabolic rate in patients from southern Brazil
- 1 January 2011
- journal article
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 46 (1) , 42-46
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Review of the safety and efficacy of imiglucerase treatment of Gaucher diseaseBiologics: Targets and Therapy, 2009
- A cross-sectional, mono-centric pilot study of insulin resistance in enzyme replacement therapy patients with Gaucher type I without overweightMolecular Genetics and Metabolism, 2009
- Overweight, insulin resistance and type II diabetes in type I Gaucher disease patients in relation to enzyme replacement therapyBlood Cells, Molecules, and Diseases, 2008
- Type I Gaucher Disease, a Glycosphingolipid Storage Disorder, Is Associated with Insulin ResistanceThe Journal of Clinical Endocrinology & Metabolism, 2008
- Prominent increase in plasma ganglioside GM3 is associated with clinical manifestations of type I Gaucher diseaseClinica Chimica Acta, 2008
- Very low serum adiponectin levels in patients with type 1 Gaucher disease without overt hyperglycemiaMetabolism, 2007
- Best Practice Methods to Apply to Measurement of Resting Metabolic Rate in Adults: A Systematic ReviewJournal of the American Dietetic Association, 2006
- Gaucher disease: lessons from a decade of therapyThe Journal of Pediatrics, 2004
- Differential Effects of Enzyme Supplementation Therapy on Manifestations of Type 1 Gaucher DiseaseThe American Journal of Medicine, 1997
- Resting energy expenditure in Gaucher's disease type 1: Effect of Gaucher's cell burden on energy requirementsMetabolism, 1989